Mostafa A. Elhendawy

Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers

Hazem A. Mahdy, M.K. Ibrahim, Ahmed M. Metwaly et al. · Bioorganic Chemistry · 2019 · 163 citations

Medicinal Chemistry, Novel Therapy, Medicine +9

Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors

M.K. Ibrahim, Mohammed S. Taghour, Ahmed M. Metwaly et al. · European Journal of Medicinal Chemistry · 2018 · 129 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Pharmaceutical Chemistry +13

Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation

Khaled El‐Adl, Helmy Sakr, Reda G. Yousef et al. · Bioorganic Chemistry · 2021 · 105 citations

Medicinal Chemistry, Drug Targeting, Medicine +7

Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad et al. · Bioorganic & Medicinal Chemistry · 2020 · 91 citations · Full text

Medicinal Chemistry, Medicine, Anti-proliferative Evaluation +8

Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma

Ibrahim H. Eissa, M.K. Ibrahim, Ahmed M. Metwaly et al. · Bioorganic Chemistry · 2020 · 91 citations

Medicinal Chemistry, Medicine, Vegfr-2 Inhibitors +8